Phase I study of combination therapy with endoscopic triamsinolone injection and fluticasone swallowing for the prevention of esophageal stricture after endoscopic submucosal dissectio
Phase 1
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000010383
- Lead Sponsor
- Ishikawa prefectural central hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnant or lacting women. 2)Active infection. 3)Psychosis. 4)Simulataneous double cancers. 5)Severe diabetes mellitus. 6)Patients who have been judged as inappropriate for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of dose limiting toxicity (DLT)
- Secondary Outcome Measures
Name Time Method Proportion of adverse events Rate of esophageal stricture